Xiaolin Hou | Veterinary Pharmacology | Best Researcher Award

Published on by Global Diseases Research

Mr. Xiaolin Hou | Veterinary Pharmacology | Best Researcher Award 

Professor | Beijing University of Agriculture | China

Dr. Xiaolin Hou is a distinguished researcher affiliated with Beijing University of Agriculture, specializing in veterinary virology, immunology, and nanobiotechnology applications in animal health. With a prolific portfolio of 58 publications and over 1,200 citations, Dr. Hou has significantly contributed to the understanding of viral pathogenesis and host immune modulation, particularly in chronic hepatitis B and porcine reproductive and respiratory syndrome virus. His research emphasizes innovative approaches to disease prevention and therapeutic interventions, including nanoparticle-mediated drug delivery, quantum dot polymer inhibitors, and advanced immunoassay techniques for mycotoxin detection. Collaborating extensively with a global network of 174 co-authors, Dr. Hou integrates multidisciplinary expertise across molecular biology, food safety, and pharmaceutical sciences to develop practical solutions for veterinary and public health challenges. His work demonstrates a consistent focus on enhancing immune responses, suppressing pathogenic mechanisms, and improving disease diagnostics, reflecting both academic rigor and societal impact. Notably, Dr. Hou’s research bridges fundamental science with applied technologies, fostering advancements in animal therapeutics, vaccine development, and food safety monitoring. Recognized for both methodological innovation and translational relevance, his contributions continue to shape contemporary approaches in veterinary pharmacology and virology research on an international scale.

Profiles: Scopus | ORCID

Featured Publications

1. Han, C., Xu, W., Wang, J., Hou, X., Zhou, S., Song, Q., Liu, X., & Li, H. (2023). Porcine circovirus 2 increases the frequency of transforming growth factor-β via the C35, S36 and V39 amino acids of the ORF4. Viruses, 15(7), 1602.

2. Liu, X., Wang, Y., Han, C., Li, Q., Hou, X., Song, Q., Zhou, S., & Li, H. (2022). TGF-β from the porcine intestinal cell line IPEC-J2 induced by porcine circovirus 2 increases the frequency of Treg cells via the activation of ERK (in CD4⁺ T cells) and NF-κB (in IPEC-J2). Viruses, 14(11), 2466

3. Hou, X. (2022). A berberine hydrochloride–carboxymethyl chitosan hydrogel protects against Staphylococcus aureus infection in a rat mastitis model. Carbohydrate Polymers, 282, 118910.

4. Hou, X. (2022). Lithium chloride inhibits infectious bronchitis virus-induced apoptosis and inflammation. Microbial Pathogenesis, 162, 105352.

5. Hou, X. (2021). Antibacterial activity and membrane-targeting mechanism of aloe-emodin against Staphylococcus epidermidis. Frontiers in Microbiology, 12, 621866.

Dr. Xiaolin Hou’s research advances animal and human health through innovative applications of nanotechnology, immunoassays, and antiviral strategies. By elucidating molecular mechanisms in viral infections and immune modulation, their work contributes to disease prevention, therapeutic development, and global food safety, bridging fundamental science with practical solutions for public health and veterinary medicine.